{"doi":"10.1161/strokeaha.123.043358","title":"Thrombolysis for Wake-Up Stroke Versus Non–Wake-Up Unwitnessed Stroke: EOS Individual Patient Data Meta-Analysis","abstract":"BACKGROUND: Stroke with unknown time of onset can be categorized into 2 groups; wake-up stroke (WUS) and unwitnessed stroke with an onset time unavailable for reasons other than wake-up (non–wake-up unwitnessed stroke, non-WUS). We aimed to assess potential differences in the efficacy and safety of intravenous thrombolysis (IVT) between these subgroups. METHODS: Patients with an unknown-onset stroke were evaluated using individual patient-level data of 2 randomized controlled trials (WAKE-UP [Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke], THAWS [Thrombolysis for Acute Wake-Up and Unclear-Onset Strokes With Alteplase at 0.6 mg/kg]) comparing IVT with placebo or standard treatment from the EOS (Evaluation of Unknown-Onset Stroke Thrombolysis trial) data set. A favorable outcome was prespecified as a modified Rankin Scale score of 0 to 1 at 90 days. Safety outcomes included symptomatic intracranial hemorrhage at 22 to 36 hours and 90-day mortality. The IVT effect was compared between the treatment groups in the WUS and non-WUS with multivariable logistic regression analysis. RESULTS: Six hundred thirty-four patients from 2 trials were analyzed; 542 had WUS (191 women, 272 receiving alteplase), and 92 had non-WUS (42 women, 43 receiving alteplase). Overall, no significant interaction was noted between the mode of onset and treatment effect ( P value for interaction=0.796). In patients with WUS, the frequencies of favorable outcomes were 54.8% and 45.5% in the IVT and control groups, respectively (adjusted odds ratio, 1.47 [95% CI, 1.01–2.16]). Death occurred in 4.0% and 1.9%, respectively ( P =0.162), and symptomatic intracranial hemorrhage in 1.8% and 0.3%, respectively ( P =0.194). In patients with non-WUS, no significant difference was observed in favorable outcomes relative to the control (37.2% versus 29.2%; adjusted odds ratio, 1.76 [0.58–5.37]). One death and one symptomatic intracranial hemorrhage were reported in the IVT group, but none in the control. CONCLUSIONS: There was no difference in the effect of IVT between patients with WUS and non-WUS. IVT showed a significant benefit in patients with WUS, while there was insufficient statistical power to detect a substantial benefit in the non-WUS subgroup. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: CRD42020166903.","journal":"Stroke","year":2024,"id":438189,"datarank":0.612844103275417,"base_score":2.3978952727983707,"endowment":2.3978952727983707,"self_citation_contribution":0.3596842909197557,"citation_network_contribution":0.2531598123556613,"self_endowment_contribution":0.3596842909197557,"citer_contribution":0.2531598123556613,"corpus_percentile":null,"corpus_rank":null,"citation_count":10,"citer_count":9,"citers_with_citation_signal":5,"citers_with_endowment":5,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.7823,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["CRD42020166903"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":249929,"name":"Kaori Miwa","orcid":"0000-0002-7948-3636","position":1,"is_corresponding":false},{"id":249944,"name":"Ḱazunori Toyoda","orcid":"0000-0002-8346-9845","position":2,"is_corresponding":false},{"id":1248005,"name":"Märit Jensen","orcid":"0000-0001-7793-0941","position":3,"is_corresponding":false},{"id":249923,"name":"Manabu Inoue","orcid":"0000-0001-5228-6643","position":4,"is_corresponding":false},{"id":249942,"name":"Sohei Yoshimura","orcid":"0000-0002-4751-3538","position":5,"is_corresponding":false},{"id":249922,"name":"Mayumi Fukuda‐Doi","orcid":"0000-0003-0922-4417","position":6,"is_corresponding":false},{"id":1248006,"name":"Takanari Kitazono","orcid":"0000-0002-9006-5937","position":7,"is_corresponding":false},{"id":249911,"name":"Florent Boutitie","orcid":"0000-0002-2538-7219","position":8,"is_corresponding":false},{"id":249912,"name":"Henry Ma","orcid":"0000-0002-0510-8059","position":9,"is_corresponding":false},{"id":620448,"name":"Peter A. Ringleb","orcid":"0000-0002-5473-8671","position":10,"is_corresponding":false},{"id":249915,"name":"Ona Wu","orcid":"0000-0002-5509-9461","position":11,"is_corresponding":false},{"id":249914,"name":"Lee H. Schwamm","orcid":"0000-0003-0592-9145","position":12,"is_corresponding":false},{"id":249943,"name":"Steven Warach","orcid":"0000-0003-3125-7979","position":13,"is_corresponding":false},{"id":45303,"name":"Werner Hacke","orcid":"0000-0002-6951-6182","position":14,"is_corresponding":false},{"id":249946,"name":"Stephen M. Davis","orcid":"0000-0003-0962-2300","position":15,"is_corresponding":false},{"id":249945,"name":"Geoffrey A. Donnan","orcid":"0000-0001-6324-3403","position":16,"is_corresponding":false},{"id":249947,"name":"Christian Gerloff","orcid":"0000-0002-6484-8882","position":17,"is_corresponding":false},{"id":249910,"name":"Götz Thomalla","orcid":"0000-0002-4785-1449","position":18,"is_corresponding":false},{"id":249913,"name":"Masatoshi Koga","orcid":"0000-0002-6758-4026","position":19,"is_corresponding":false},{"id":249918,"name":"Bastian Cheng","orcid":"0000-0003-2434-1822","position":20,"is_corresponding":false},{"id":249916,"name":"Martin Bendszus","orcid":"0000-0002-9094-6769","position":21,"is_corresponding":false},{"id":1248417,"name":"Christopher Bladin","orcid":null,"position":22,"is_corresponding":false},{"id":249919,"name":"Leonid Churilov","orcid":"0000-0002-9807-6606","position":23,"is_corresponding":false},{"id":1248418,"name":"Brunce Campbell","orcid":null,"position":24,"is_corresponding":false},{"id":249932,"name":"Mark Parsons","orcid":"0000-0001-8874-2487","position":25,"is_corresponding":false},{"id":249941,"name":"Nawaf Yassi","orcid":"0000-0002-0685-0060","position":26,"is_corresponding":false},{"id":249920,"name":"Martin Ebinger","orcid":"0000-0002-5073-4665","position":27,"is_corresponding":false},{"id":23046,"name":"Matthias Endres","orcid":"0000-0001-6520-3720","position":28,"is_corresponding":false},{"id":249921,"name":"Jochen B. Fiebach","orcid":"0000-0002-7936-6958","position":29,"is_corresponding":false},{"id":249924,"name":"Timothy Kleinig","orcid":"0000-0003-4430-3276","position":30,"is_corresponding":false},{"id":249925,"name":"Lawrence L. Latour","orcid":"0000-0001-6160-5263","position":31,"is_corresponding":false},{"id":249926,"name":"Robin Lemmens","orcid":"0000-0002-4948-5956","position":32,"is_corresponding":false},{"id":249927,"name":"Christopher Levi","orcid":"0000-0002-9474-796X","position":33,"is_corresponding":false},{"id":249928,"name":"Didier Leys","orcid":"0000-0003-4408-4392","position":34,"is_corresponding":false},{"id":819054,"name":"Carlos A. Molina","orcid":"0000-0001-6058-6259","position":35,"is_corresponding":false},{"id":249930,"name":"Keith W. Muir","orcid":"0000-0001-9535-022X","position":36,"is_corresponding":false},{"id":249931,"name":"Norbert Nighoghossian","orcid":"0000-0003-0594-4409","position":37,"is_corresponding":false},{"id":249933,"name":"Salvador Pedraza","orcid":"0000-0003-2517-4413","position":38,"is_corresponding":false},{"id":249934,"name":"Peter D. Schellinger","orcid":"0000-0002-8517-0353","position":39,"is_corresponding":false},{"id":1248007,"name":"Stefan Schwab","orcid":"0000-0001-9058-0632","position":40,"is_corresponding":false},{"id":249936,"name":"Claus Z. Simonsen","orcid":"0000-0003-1363-0266","position":41,"is_corresponding":false},{"id":249937,"name":"Shlee Song","orcid":"0000-0002-7838-0205","position":42,"is_corresponding":false},{"id":249938,"name":"Vincent Thijs","orcid":"0000-0002-6614-8417","position":43,"is_corresponding":false},{"id":45316,"name":"Danilo Toni","orcid":"0000-0003-2735-8427","position":44,"is_corresponding":false},{"id":249939,"name":"Chung Y. Hsu","orcid":"0000-0002-5632-2733","position":45,"is_corresponding":false},{"id":45315,"name":"Nils Wahlgren","orcid":"0000-0002-0421-8838","position":46,"is_corresponding":false},{"id":1248004,"name":"Naruhiko Kamogawa","orcid":"0000-0002-5177-8248","position":0,"is_corresponding":true}],"reference_count":35,"raw_metadata":null,"created_at":"2026-07-19T02:00:38.888629Z","pmid":"38456303","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}